ETHICAL DILEMMA 3
Theadvertisement of medical and pharmaceutical products has been underthe regulatory authority of the Food and Drug Administration sincethe 1962 Kefauver-Harris Amendments. As such, they have been puttingin place regulatory measures, and which are considered as legalobligations in the control of direct-to –consumer advertisements ofmedical and pharmaceutical products. In particular, a notice ofproposed rulemaking was done in 2009 with the intention ofimplementing some of the provisions of the FDA Amendment Act of 2007which requires that there should be a major statement of the sideeffects as well as the possible risks. As per the statute, thisstatement should be very clear and unbiased.
Somepeople may want to remain young forever and this creates a businessopportunity to the manufacturers. With an intention of making a boomand increasing the sales and hence the profitability, advertisingbecomes essential. However, at times advertising is deceiving. Thenature of the adverts is meant to be rhetoric and able to convince asmany people as possible to purchase the product(White , 1993).However, in our case, we realize that most of the old people and whoare desperate to regain their original looks or want to prevent signsof ageing in them easily fall prey to the adverts. However, it is nota guarantee that the products will offer the desired results. Ofcourse, during the advert, the manufacturer cannot state that theresults are not guaranteed as it may keep of some of the potentialclients and who are after the results and nothing less. On the otherhand, those treatments are revolutionary n relieving suffering. Thismeans that the product can work in either way, but a dilemma existsin terms of how the message should be passed to the potentialclients. Ethics demand that one evaluates the possible consequence sand the most appropriate action to be taken. As such, it would not beright to hide the information about the probability of achieving theexpected results. To solve the dilemma, the actual information shouldbe communicated, but also not forgetting to state that the treatmentis revolutionary. This way, the product will still sell withoutbreaking the code of conduct.
White, T. (1993). Ethics.New York: MacMillan Publishers.